Repeated mammographic screening reduces breast cancer mortality along the continuum of age

Journal of Medical Screening

Volumn 9, Issue 4, 2002, Pages 163-167

  Broeders, M J M ^a   Verbeek, A L M ^a   Straatman, H ^a   Peer, P G M ^a   Pasker De Jong, P C M ^a   Beex, L V A M ^a   Hendriks, J H C L ^a   Holland, R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; RISK ASSESSMENT; SCREENING TEST;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NETHERLANDS; ODDS RATIO; RISK REDUCTION BEHAVIOR;

EID: 0036972370     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.9.4.163     Document Type: Article

References (30)

1. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis [see comments]. JAMA 1995;273:149-54.
2. Van Dijck JAAM, Broeders MJM, Verbeek ALM. Mammographic screening in older women. Is it worthwhile? Drugs Aging 1997;10:69-79.
3. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin 2000;50:312-36.
4. NIH Consensus Statement. Breast cancer screening for women ages 40-49, J Natl Cancer Inst 1997;89:1015-26.
5. Hendrick RE, Smith RA, Rutledge III JH, et al. Benefit of screening mammography in women ages 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87-92.
6. Costanza ME. Issues in breast cancer screening in older women. Cancer 1994;74:2009-15.
7. Van Dijck JAAM, Holland R, Verbeek ALM, et al. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands, J Natl Cancer Inst 1994;86:934-8.
8. Chen HH, Tabar L, Fagerberg G, et al. Effect of breast cancer screening after age 65. J Med Screen 1995;2:10-14.
9. Van Dijck JAAM, Verbeek ALM, Beex LVAM, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer 1996;66:727-31.
10. Boer R, De Koning HJ, Van Oortmarssen GJ, et al. In search of the best upper age limit for breast cancer screening. Eur J Cancer 1995;31A:2040-3.
11. Often JDM, Van Dijck JAAM, Peer PGM, et al. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 1996;50:353-8.
12. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
13. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982;116:547-53.
14. Moss SM. Case-control studies of screening, Int J Epidemiol 1991;20:1-6.
15. Demissie K, Mills OF, Rhoads GG. Empirical comparison of the results of randomised controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 1998;51:81-91.
16. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-18.
17. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
18. Cronin KA, Weed DL, Connor RJ, et al. Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 1998;90:498-504.
19. UK Trial of Early Detection of Breast Cancer group. Sixteen year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 1999;353:1909-14.
20. De Koning HJ, Boer R, Warmerdam PG, et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials [see comments]. J Natl Cancer Inst 1995;87:1217-23.
21. Tabar L, Duffy SW, Chen HH. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1996;88:52-5.
22. Miltenburg GAJ, Peeters PHM, Fracheboud J, et al. Seventeen year evaluation of breast cancer screening: the DOM project, The Netherlands. Br J Cancer 1998;78:962-5.
23. Palli D, Rosselli del Turco M, Buiatti E, et al. Time interval since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Community Health 1989;43:241-8.
24. Weiss NS, McKnight B, Stevens NG. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 1992;135:817-23.
25. Etzioni RD, Weiss NS. Analysis of case-control studies of screening: impact of misspecifying the duration of detectable preclinical pathologic changes. Am J Epidemiol 1998;148:292-7.
26. Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-62.
27. Peer PGM, Van Dijck JAAM, Hendriks JHCL, et al. Age dependent growth rate of primary breast cancer. Cancer 1993;71:3547-51.
28. Kerlikowske K, Salzmann P, Phillips KA, et al. Continuing screening mammography in women aged 70 to 79 years. Impact on life expectancy and cost-effectiveness. JAMA 1999;282:2156-63.
29. Moss S, for the Trial Steering Group. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. J Med Screen 1999;6:144-8.
30. Smith-Bindman R, Kerlikowske K, Gebretsadik T, et al. Is screening mammography effective in elderly women? Am J Med 2000;108:112-19.